Celltrion Healthcare Ireland Limited.
Every public sector contract Celltrion Healthcare Ireland Limited. has won, with the buyer, value and end date for each. When these contracts approach their end date they usually return to the market. Business predicts when, follows Celltrion Healthcare Ireland Limited. for you, and alerts you the moment a renewal goes live.
Where they win
The sectors, tender types and buyers where Celltrion Healthcare Ireland Limited. wins most often.
See every live public sector tenders and find your next contract before they do.
Similar suppliers
See all NHS buyers and UK contract awards.
Sectors
Top Buyers
Awards(13)
DPS Tender for the Supply of Bevacizumab Conc Soln for Infusion to St James’s Hospital
DPS Tender for the Supply of Trastuzumab 150mg and 420mg intravenous to South East Health Region
DPS Tender for Bevacizumab Concentrate for Solution for Infusion Pharmaceutical Products to Beaumont Hospital and Our Lady of Lourdes Hospital, Drogheda
Ireland – Pharmaceutical products – Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal Products
Ireland – Pharmaceutical products – Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal Products
Ireland – Pharmaceutical products – Dynamic Purchasing System (DPS) Invitation for the provision of Authorised Medicinal Products
MINI COMPETITION FOR THE SUPPLY OF RITUXIMAB SOLUTION FOR INFUSION
THE SUPPLY OF RITUXIMAB FOR INFUSION
DPS Tender for the Supply of Infliximab Intravenous Infusion HSE West and North West
HSE 25092 Supply of Infliximab Intravenous Infusion to Connolly Hospital Blanchardstown and Our Ladys Hospital Navan
DPS Tender for the Supply of Rituximab Solution for Infusion – CHI Hospital Group
Supply of Infliximab Intravenous Infusion to Children’s Health Ireland Hospital Group
DPS Tender for the Supply of Rituximab Solution for Infusion to the Mater Misericordiae University Hospital
Know when Celltrion Healthcare Ireland Limited.'s contracts come up for renewal
Business predicts when each of these contracts is due to be re-tendered, follows Celltrion Healthcare Ireland Limited. for you, and alerts you the moment a renewal goes live, so you can bid before the incumbent locks it in again.
Why track Celltrion Healthcare Ireland Limited.?
Celltrion Healthcare Ireland Limited. is an active supplier to UK public sector buyers. Their contract history is one of the clearest guides to where the work is: which authorities they serve, what those contracts are worth, and, most usefully, when each contract is due to end. A contract nearing its end date is an opportunity, because the buyer will usually run the work again.
How renewal tracking works
We aggregate Celltrion Healthcare Ireland Limited.'s award notices from 600+ UK and Irish sources and read the end date on each contract. From those dates, Business predicts when each contract is likely to be re-tendered and, if you follow the supplier, alerts you the moment a matching tender goes live. That head start lets you speak to the buyer and prepare a bid before the incumbent is confirmed again.
What you can do here
- Review the full history. Every contract Celltrion Healthcare Ireland Limited. has won, with the buyer, value and dates for each.
- Spot upcoming renewals. Contracts approaching their end date are the ones most likely to reopen.
- Track and get alerted. Follow Celltrion Healthcare Ireland Limited. and be notified when their contracts come up again (Business).
- Benchmark and target. See which buyers rely on them and at what value, then focus where you can win.
Frequently asked questions
Where does this data come from?
Official UK and Irish contract award notices, aggregated from 600+ sources and updated daily.
Is the contract history free?
Yes. The full award history, values and buyers are free to browse. Predicted renewal dates, following a supplier and renewal alerts are part of our Business plans.
How do you predict renewals?
From the end dates and durations recorded on awarded contracts. A contract at or near its end date is a strong candidate to return to the market.